CollPlant Biotechnologies Ltd (CLGN) stock
CLGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as OPHI
$3.96+0.06 (+1.54%)
Close on Nov 11, 2026Market cap –P/E –Yield –
CollPlant Biotechnologies operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2025 it was -484.3%, against -3349.7% the year before. The highest annual figure on record is 0.4% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -484.3% | +2865.4 |
| FY2024 | Dec 31, 2024 | -3349.7% | −3281.2 |
| FY2023 | Dec 31, 2023 | -68.5% | +5649.5 |
| FY2022 | Dec 31, 2022 | -5718.1% | −5718.5 |
| FY2021 | Dec 31, 2021 | 0.4% | +91.6 |
| FY2020 | Dec 31, 2020 | -91.2% | +238.0 |
| FY2019 | Dec 31, 2019 | -329.2% | −244.5 |
| FY2018 | Dec 31, 2018 | -84.7% | +1201.9 |
| FY2017 | Dec 31, 2017 | -1286.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2025 | Jun 30, 2025 | -1775.4% | −1332.1 |
| Q2 FY2024 | Jun 30, 2024 | -1769.5% | −1537.0 |
| Q2 FY2023 | Jun 30, 2023 | 55.7% | +346.3 |
| Q2 FY2022 | Jun 30, 2022 | -6340.9% | −5577.7 |
| Q2 FY2021 | Jun 30, 2021 | -443.3% | – |
| Q2 FY2020 | Jun 30, 2020 | -232.4% | – |
| Q2 FY2019 | Jun 30, 2019 | -290.6% | – |
| Q2 FY2018 | Jun 30, 2018 | -763.2% | – |
See a number that looks wrong?